All News & Research Articles

Jason Meyer, PhD, is a BrightFocus Foundation success story and a pioneer in the effort to regenerate eye tissue that is damaged by glaucoma. 

Recently, when their groundbreaking genetics discovery was featured on the cover of Nature, the research team thanked BrightFocus for critical early funding that supported their accomplishments.

Working to save sight, BrightFocus’ National Glaucoma Research program is supporting Kathryn Burdon, PhD, of Australia’s University of Tazmania and Girum Gessesse, MD, of Ethiopia’s St. Paul’s Hospital Millennium Medical College to expand our scientific understanding of glaucoma in Africa.

The research and discoveries of clinician-scientist Joel S. Schuman, MD, are having a big impact on vision diseases, including glaucoma. Early support from BrightFocus had a big impact on his career.

Two new pressure-lowering glaucoma medications have been approved by the FDA and are becoming available in the United States. Each is unique, and one is the first in a new class of drugs.

BrightFocus Foundation has joined a new partnership to support innovative science to regenerate damaged visual pathways in glaucoma.

Read our interview with Dr. Elliott where he talks about his original hypothesis and his exciting new research directions.

BrightFocus Foundation recently held its first-ever Glaucoma FastTrack to accelerate the fight for a cure by investing in promising young scientists in the field of vision research.